ResMed shares slip after Q2 FY26 results release
ResMed Inc (NYSE: RMD) shares closed at $257.41, down 0.12% on the day. The stock moved lower following the release of the company’s second-quarter fiscal…
Earnings Transcripts
View All →
Visa Reports 15% Revenue Growth in Fiscal Q1 as Cross-Border Volume Offsets Expense Rise
Apple Posts Record Q1 Profit, Margins Expand Despite Supply Constraints
Apple Posts Record $143.8 Billion Revenue for Q1 2026 as iPhone Sales Surge
